Vendor, Charlottesville, VA
Atelerix Life Sciences Inc.
UEI TD8NL4UWNVW8, CAGE 8ZNE9
1 award and -$680,885 obligated between July 23, 2024 and July 23, 2024, 0% under full and open competition, against 100.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | -$680,885 |
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | -$680,885 |
How it wins
Awards by competition, set-aside and type.
| Competed Under SAP | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50123C00053Definitive Contract, July 23, 2024, Competed Under SAP, 100 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Atelerix - the Overall Objective of This Contract Is to Plan and Execute a Phase 1A Clinical Trial (Hereafter Referred to as the ?phase 1A TNAICS 541715, PSC AN13 | -$680,885 |
- Places of performance
- Virginia
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 1 across 1 awards